CRP and acute graft versus host disease: A Kaplan–Meier analysis showed that cumulative probability of AKI in the first 100 days after HSCT was higher in patients with CsA overdose (96.9% vs. 59.8%, p < 0.001), TAC overdose (100% vs. 66.7%, p = 0.04), presence of acute GVHD (89.5% vs. 65.5%, p = 0.01) and CRP level >25 mg/L (83.6% vs. 58.7%, p < 0.001) (Figure 2).